Our Orbital™ Dry Powder Inhaler technology releases the dry powder formulation through one or more inhalations until the full dose is delivered, which reduces the risk of coughing. The technology can reliably deliver high doses of dry powder formulations directly to the lungs.
Orbital™ Dry Powder Inhaler systems provide accurate and reproducible dosing with flexibility in the number of inhalations per dose, to help with patient compliance. With reusable and single use applications the Orbital™ DPI devices can be fine-tuned to meet the specific needs of your dry powder inhalation product.
After a single priming step, the patient simply inhales their treatment. No hand-breath coordination is needed. The innovative design allows delivery of the full dose of treatment directly to the lungs, with shorter treatment administration times than traditional capsule-based inhalers or nebulizer treatments.
The Orbital™ Dry Powder Inhaler system is easy and convenient for patients to use, and can help increase patient acceptance and compliance with their treatment.
The advanced design offers technical drug delivery advantages, in a hand-held, easy to use format, with brand differentiation opportunities. This leading-edge technology is protected by numerous patents, supporting long-term exclusivity.